A new KFF analysis finds that there were 44 million people enrolled in health coverage through the Affordable Care Act’s Marketplaces and its expansion of the Medicaid program in 2024. That represents about 1 in every 6 people under age 65, or 16.4%. There was significant variation in ACA enrollment across states, ranging from…More
Following Brexit, the funding infrastructure for new buyout funds in the UK has broken down. These new managers are now struggling to find anchor investors and offer an opportunity to the private sector to step in and secure attractive returns. The post The Opportunity being Missed in UK Healthcare Buyouts appeared first on MedCity News.
This test can be thought of as a crystal ball for cancer survivors and research has found it can predict with near certainty whether a patient’s cancer will recur. So why aren’t more patients getting the test? The post A Crystal Ball for Cancer Survivors appeared first on MedCity News.
Ann Bauer, una investigadora que estudia la relación entre el Tylenol y el autismo, se sintió mareada de la ansiedad en las semanas previas al tan anticipado anuncio sobre autismo de la Casa Blanca. En agosto, Bauer y sus colegas publicaron un análisis de 46 estudios previos sobre Tylenol, autismo y trastorno por déficit de…
Albert Bourla and other healthcare CEOs talked about the efficacy of vaccines and how public health could take a big turn for the worse if the incoming Trump administration veered away from accepted norms regarding vaccines. The post Pfizer CEO At JPM Issues Clear Warning to Kennedy on Vaccines appeared first on MedCity News.
One Phase 3 test of Auvelity met its main goal in Alzheimer’s agitation while the drug’s other pivotal trial showed numerical improvement that fell short of statistical significance. Axsome Therapeutics aims to offer an alternative to Rexulti, a Lundbeck and Otsuka Pharmaceutical product that is the only FDA-approved Alzheimer’s agitation drug. The post Axsome Aims…
This analysis examines the potential impacts on states and Medicaid enrollees of eliminating the 90% federal match rate for the Affordable Care Act (ACA) expansion. Eliminating the federal match rate for adults in the Medicaid expansion could reduce Medicaid spending by nearly one-fifth ($1.9 trillion) over a 10-year period and up to nearly a quarter…
Healthcare providers are making cybersecurity progress, but serious vulnerabilities remain — especially when it comes to AI governance, third-party risk, and limited budgets. Fortified Health Security CEO Dan Dodson urged the industry to stop waiting for perfect conditions and act decisively to strengthen their defenses. The post Despite Progress, Healthcare Cybersecurity Is Still Falling Short…
The new generation of healthcare AI innovation is promising, but there are some problems that remain when it comes to AI, such as data generalization and the high cost of adopting new tools, pointed out Dr. Arash Harzand. The post AI Holds Promise, But Concerns Around Costs and Data Remain appeared first on MedCity News.
Christina Kashiwada was traveling for work during the summer of 2018 when she noticed a small, itchy lump in her left breast. She thought little of it at first. She did routine self-checks and kept up with medical appointments. But a relative urged her to get a mammogram. She took the advice and learned she…